Session 3
29
RÉFÉRENCES
1.- Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Type
2 diabetes as a "coronary heart disease equivalent": an 18-year
prospective population-based study in Finnish subjects. Diabetes
Care 28:2901-2907, 2005
2.- Danchin N, Oswald T, Voiriot P, Juilliere Y, Cherrier F: Signi-
cance of spontaneous obstruction of high degree coronary artery
stenoses between diagnostic angiography and later percuta-
neous transluminal coronary angioplasty. Am J Cardiol 63:660-
662, 1989
3.- Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico
JA, Friedman J, Diamond GA: Incremental prognostic value of
myocardial perfusion single photon emission computed tomo-
graphy for the prediction of cardiac death: dierential stratica-
tion for risk of cardiac death and myocardial infarction. Circulation
97:535-543, 1998
4.- Vanzetto G, Ormezzano O, Fagret D, Comet M, Denis B, Mache-
court J: Long-term additive prognostic value of thallium-201
myocardial perfusion imaging over clinical and exercise stress test
in low to intermediate risk patients : study in 1137 patients with
6-year follow-up. Circulation 100:1521-1527, 1999
5.- Steinberg EH, Madmon L, Patel CP, Sedlis SP, Kronzon I, Cohen
JL: Long-term prognostic signicance of dobutamine echocardio-
graphy in patients with suspected coronary artery disease: results
of a 5-year follow-up study. J Am Coll Cardiol 29:969-973, 1997
6.- Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R,
Fleck E, Paetsch I: Prognostic value of cardiac magnetic resonance
stress tests: adenosine stress perfusion and dobutamine stress
wall motion imaging. Circulation 115:1769-1776, 2007
7.- Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg
S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti
L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL,
Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Tag-
gart D: Guidelines on myocardial revascularization. Eur Heart J
31:2501-2555, 2010
8.- Jacqueminet S, Barthelemy O, Rouzet F, Isnard R, Halbron M,
Bouzamondo A, Le Guludec D, Grimaldi A, Metzger JP, Le Feuvre
C: A randomized study comparing isotope and echocardiography
stress testing in the screening of silent myocardial ischaemia in
type 2 diabetic patients. Diabetes Metab 36:463-469, 2010
9.- Yamasaki Y, Nakajima K, Kusuoka H, Izumi T, Kashiwagi A,
Kawamori R, Shimamoto K, Yamada N, Nishimura T: Prognostic
value of gated myocardial perfusion imaging for asymptomatic
patients with type 2 diabetes: the J-ACCESS 2 investigation. Dia-
betes Care 33:2320-2326, 2010
10.- Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taille-
fer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, Ratner RE,
Inzucchi SE: Cardiac outcomes after screening for asymptomatic
coronary artery disease in patients with type 2 diabetes: the DIAD
study: a randomized controlled trial. Jama 301:1547-1555, 2009
11.- Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cif-
kova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herr-
mann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori
SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op
Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E,
Fitzgerald T, Cooney MT, Dudina A: European guidelines on car-
diovascular disease prevention in clinical practice: executive sum-
mary: Fourth Joint Task Force of the European Society of Cardio-
logy and Other Societies on Cardiovascular Disease Prevention in
Clinical Practice (Constituted by representatives of nine societies
and by invited experts). Eur Heart J 28:2375-2414, 2007
12.- Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, Mac-
Gregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH,
Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE:
A randomized trial of therapies for type 2 diabetes and coronary
artery disease. N Engl J Med 360:2503-2515, 2009
13.- Kamalesh M, Feigenbaum H, Sawada S: Challenge of iden-
tifying patients with diabetes mellitus who are at low risk for
coronary events by use of cardiac stress imaging. Am Heart J
147:561-563, 2004
14.- Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circu-
lation 92:657-671, 1995
15.- Moreno PR, Murcia AM, Palacios IF, Leon MN, Bernardi
VH, Fuster V, Fallon JT: Coronary composition and macrophage
inltration in atherectomy specimens from patients with diabetes
mellitus. Circulation 102:2180-2184, 2000
Comment et quand dépister l’ischémie myocardique chez le patient diabétique ?